{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T17:30:38Z","timestamp":1792863038203,"version":"4.5.0"},"reference-count":27,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2010,1,19]],"date-time":"2010-01-19T00:00:00Z","timestamp":1263859200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Science"],"published-print":{"date-parts":[[2010,5]]},"abstract":"<jats:p>This retrospective study was launched to evaluate the efficacy of doxycycline and to find independent predictors of a clinical response in patients with ocular adnexal lymphoma of mucosa\u2010associated lymphoid tissue (OAML). Thirty\u2010eight patients with newly diagnosed, localized OAML received doxycycline for 3\u2003weeks (12 patients) or 6\u2003weeks (26 patients). Clinical factors including absolute lymphocyte count (ALC) and neutrophil count (ANC) were compared between responders and non\u2010responders. After a median follow\u2010up of 26.4\u2003months, doxycycline resulted in an overall response rate of 47% and a 3\u2010year time\u2010to\u2010treatment failure (TTF) rate of 84%. Patients treated with doxycycline for 6\u2003weeks <jats:italic>versus<\/jats:italic> 3\u2003weeks tended to have a higher response rate (54%<jats:italic>vs<\/jats:italic> 33%). Absolute lymphocytosis (ALC\u2003&gt;\u20033.01\u2003\u00d7\u200310<jats:sup>9<\/jats:sup>\/L) and absolute neutrophilia (ANC\u2003&gt;\u20031.92\u2003\u00d7\u200310<jats:sup>9<\/jats:sup>\/L) were defined based on the median value of each count. Patients with (19 patients) <jats:italic>versus<\/jats:italic> without absolute lymphocytosis had significantly shorter 2\u2010year TTF (70%<jats:italic>vs<\/jats:italic> 100%, <jats:italic>P<\/jats:italic>\u2003=\u20030.021) and a lower response rate (32%<jats:italic>vs<\/jats:italic> 63%, <jats:italic>P<\/jats:italic>\u2003=\u20030.051). Absolute lymphocytosis (odds ratio [OR]\u2003=\u20034.7; 95% confidence interval [CI], 1.1\u201320.8; <jats:italic>P<\/jats:italic>\u2003=\u20030.043) and non\u2010conjunctival tumor (OR\u2003=\u200311.8; 95% CI, 1.1\u2013122.5; <jats:italic>P<\/jats:italic>\u2003=\u20030.038) were negative predictors for response by multivariate analysis. Front\u2010line doxycycline is effective particularly in localized OAML patients without absolute lymphocytosis but with conjunctival involvement.<\/jats:p><jats:p>(<jats:italic>Cancer Sci<\/jats:italic> 2010; 101: 1199\u20131203)<\/jats:p>","DOI":"10.1111\/j.1349-7006.2010.01502.x","type":"journal-article","created":{"date-parts":[[2010,1,19]],"date-time":"2010-01-19T08:56:56Z","timestamp":1263891416000},"page":"1199-1203","source":"Crossref","is-referenced-by-count":42,"title":["First\u2010line therapy with doxycycline in ocular adnexal mucosa\u2010associated lymphoid tissue lymphoma: A retrospective analysis of clinical predictors"],"prefix":"10.1111","volume":"101","author":[{"given":"Tae Min","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki Hwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Joung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoon Kyung","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se\u2010Hoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong\u2010Wan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chul Woo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Il Han","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang In","family":"Khwarg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae Seog","family":"Heo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,4,19]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djj248"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.125.12.1668"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdm513"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-06-2332"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/path.1984"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22843"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djh102"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.07.083"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djj373"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdm561"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.20962"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-02-005017"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.12.3835"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.38.3.1085-1093.2000"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.4.1244"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.1958.10501452"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdm457"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1995.13.5.1221"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdf257"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.09.0274"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2008.08.019"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2006.06232.x"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404780"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1409"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-0676"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.172.3.1768"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdj143"}],"container-title":["Cancer Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1349-7006.2010.01502.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1349-7006.2010.01502.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T03:59:15Z","timestamp":1697428755000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1349-7006.2010.01502.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,19]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["10.1111\/j.1349-7006.2010.01502.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1349-7006.2010.01502.x","archive":["Portico"],"relation":{},"ISSN":["1347-9032","1349-7006"],"issn-type":[{"value":"1347-9032","type":"print"},{"value":"1349-7006","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,19]]}}}